These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
669 related articles for article (PubMed ID: 26826769)
1. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency. Bork K; Bernstein JA; Machnig T; Craig TJ J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769 [TBL] [Abstract][Full Text] [Related]
2. Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema. Craig TJ; Wasserman RL; Levy RJ; Bewtra AK; Schneider L; Packer F; Yang WH; Keinecke HO; Kiessling PC J Clin Immunol; 2010 Nov; 30(6):823-9. PubMed ID: 20635155 [TBL] [Abstract][Full Text] [Related]
3. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema. Riedl MA; Lumry WR; Li HH; Craig TJ; Fitts D; Kalfus I; Uknis ME Am J Rhinol Allergy; 2013; 27(6):517-21. PubMed ID: 24274230 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema. Lumry W; Soteres D; Gower R; Jacobson KW; Li HH; Chen H; Schranz J Pediatr Allergy Immunol; 2015 Nov; 26(7):674-80. PubMed ID: 26171584 [TBL] [Abstract][Full Text] [Related]
7. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients. Federici C; Perego F; Borsoi L; Crosta V; Zanichelli A; Gidaro A; Tarricone R; Cicardi M BMJ Open; 2018 Jul; 8(7):e022291. PubMed ID: 30061443 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement. Riedl MA; Li HH; Cicardi M; Harper JR; Relan A Allergy Asthma Proc; 2017 Nov; 38(6):462-466. PubMed ID: 28903805 [TBL] [Abstract][Full Text] [Related]
9. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. Riedl MA; Hurewitz DS; Levy R; Busse PJ; Fitts D; Kalfus I Ann Allergy Asthma Immunol; 2012 Jan; 108(1):49-53. PubMed ID: 22192966 [TBL] [Abstract][Full Text] [Related]
10. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema. Bork K Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050 [TBL] [Abstract][Full Text] [Related]
11. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents. Baker JW; Reshef A; Moldovan D; Harper JR; Relan A; Riedl MA J Allergy Clin Immunol Pract; 2017; 5(4):1091-1097. PubMed ID: 28202404 [TBL] [Abstract][Full Text] [Related]
12. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks. Grant JA; White MV; Li HH; Fitts D; Kalfus IN; Uknis ME; Lumry WR Allergy Asthma Proc; 2012; 33(4):348-53. PubMed ID: 22856635 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164 [TBL] [Abstract][Full Text] [Related]
14. Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks. Bernstein JA; Tyson C; Relan A; Adams P; Magar R J Manag Care Spec Pharm; 2020 Feb; 26(2):203-210. PubMed ID: 31841366 [TBL] [Abstract][Full Text] [Related]
15. New treatment options for acute edema attacks caused by hereditary angioedema. Thomas MC; Shah S Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099 [TBL] [Abstract][Full Text] [Related]
17. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children. Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks. Li HH; Reshef A; Baker JW; Harper JR; Relan A Allergy Asthma Proc; 2017 Nov; 38(6):456-461. PubMed ID: 28874235 [TBL] [Abstract][Full Text] [Related]
19. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum. KÅ‘halmi KV; Veszeli N; Cervenak L; Varga L; Farkas H Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE). Sabharwal G; Craig T Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]